NEOGENOMICS INC — Director's Dealing 2018

Mar 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-03-27

Reporting Person: Virag Sharon (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-27	Stock Option (Right to Buy)	$8.22	A	192500	Acquired	2023-03-27	Common Stock (192500.0)	Direct

Footnotes

F1: On March 27, 2018, Ms. Virag was granted an option to purchase shares of NeoGenomics, Inc. common stock. The option vests ratably over the first three anniversary dates of the grant date.